SCHEMBL20788166

SCHEMBL20788166

CCCc1cc(C)cc(CCC)c1N

nearest known ligand 0.47

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
NOS2 P35228 4/20 0.47
NOS3 P29474 2/20 0.47
NOS1 P29475 1/20 0.47
ALDH1A1 P00352 5/20 0.40
KDM4E B2RXH2 2/20 0.40
TSHR P16473 1/20 0.39
HTT P42858 2/20 0.36
TAAR1 Q96RJ0 1/20 0.35
IKBKB O14920 1/20 0.35
POLB P06746 1/20 0.34
GAA P10253 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HMGCR P04035 1/20 0.33
SKP2 Q13309 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23863705 0.89 NOS2 (0.42) NOS2NOS3NOS1ALDH1A1KDM4E
SCHEMBL6763264 0.86 NOS2 (0.50) NOS2NOS3NOS1ALDH1A1KDM4E
SCHEMBL19503247 0.85 ALDH1A1 (0.45) NOS2NOS3NOS1ALDH1A1KDM4E
SCHEMBL9326441 0.82 ALDH1A1 (0.38) NOS2NOS3NOS1ALDH1A1TSHR
SCHEMBL3797886 0.80 NOS2 (0.38) NOS2NOS3NOS1ALDH1A1KDM4E
SCHEMBL31614612 0.80 DHFR (0.35) NOS2NOS3NOS1ALDH1A1KDM4E
SCHEMBL6131303 0.80 GABRA1 (0.37) NOS2NOS3NOS1ALDH1A1HTT
SCHEMBL17734342 0.79 NOS2 (0.42) NOS2NOS3NOS1ALDH1A1KDM4E
SCHEMBL580071 0.79 HTT (0.52) NOS2NOS3NOS1ALDH1A1KDM4E
SCHEMBL20681193 0.78 HMGCR (0.41) NOS2NOS3NOS1HTTIKBKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101291990-B Thermosetting resin composition and use thereof NIPPON KAYAKU KK 2012-05-30 CN claimed
CN-101291990-A Thermosetting resin composition and use thereof NIPPON KAYAKU KK (JP) 2008-10-22 CN claimed
US-10815317-B2 Method for producing oligomer and catalyst ENEOS CORPORATION (JP) 2020-10-27 US disclosed
US-20190077888-A1 METHOD FOR PRODUCING OLIGOMER AND CATALYST JXTG NIPPON OIL & ENERGY CORPORATION (JP) 2019-03-14 US disclosed
CN-108602909-A The manufacturing method and catalyst of oligomer JXTG能源株式会社 2018-09-28 CN disclosed
CN-102575004-B Polyamide compound and epoxy resin composition containing same ADEKA CORP 2014-06-25 CN disclosed
CN-102575004-A Polyamide compound and epoxy resin composition containing same ADEKA CORP 2012-07-11 CN disclosed
CN-101379118-B Epoxy resin curable composition for prepreg ADEKA CORP 2012-07-04 CN disclosed
CN-101291990-B Thermosetting resin composition and use thereof NIPPON KAYAKU KK 2012-05-30 CN disclosed
CN-102186904-A Polyamide resin and composition thereof NIPPON KAYAKU KK 2011-09-14 CN disclosed
CN-101189275-B epoxy resin curable composition ADEKA CORP 2011-08-17 CN disclosed
CN-101652250-A Composite material ADEKA CORP JP 2010-02-17 CN disclosed
CN-101652714-A Photosensitive resin composition NIPPON KAYAKU KK JP 2010-02-17 CN disclosed
CN-101466777-A Photosensitive, aqueous alkaline solution-soluble polyimide resin and photosensitive resin composition containing the same NIPPON KAYAKU KK (JP) 2009-06-24 CN disclosed
CN-101379118-A Epoxy resin curable composition for prepreg ADEKA CORP (JP) 2009-03-04 CN disclosed
CN-101291990-A Thermosetting resin composition and use thereof NIPPON KAYAKU KK (JP) 2008-10-22 CN disclosed
CN-101189275-A epoxy resin curable composition ADEKA CORP (JP) 2008-05-28 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10815317-B2 Method for producing oligomer and catalyst AOC2, ZRANB2, PICALM NOS2 1070/4885NOS3 1560/4885NOS1 1895/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.